Market Cap 829.36M
Revenue (ttm) 76.30M
Net Income (ttm) -122.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -160.81%
Debt to Equity Ratio 0.00
Volume 1,104,600
Avg Vol 551,526
Day's Range N/A - N/A
Shares Out 69.58M
Stochastic %K 17%
Beta 1.18
Analysts Strong Sell
Price Target $21.35

Latest News on ZYME

Zymeworks Inc. (ZYME) Q4 2024 Earnings Call Transcript

Mar 5, 2025, 8:43 PM EST - 4 weeks ago

Zymeworks Inc. (ZYME) Q4 2024 Earnings Call Transcript


3 Biotech Stocks With Notable Insider Buying

Jan 22, 2025, 12:29 PM EST - 2 months ago

3 Biotech Stocks With Notable Insider Buying

AUPH AZN COGT JAZZ ONC XBI


Zymeworks Inc. (ZYME) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 10:05 PM EDT - 5 months ago

Zymeworks Inc. (ZYME) Q3 2024 Earnings Call Transcript


Zymeworks Approaching A Moment Of Truth With Zanidatamab

Sep 27, 2024, 2:47 PM EDT - 6 months ago

Zymeworks Approaching A Moment Of Truth With Zanidatamab


Zymeworks Inc. (ZYME) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 10:58 PM EDT - 8 months ago

Zymeworks Inc. (ZYME) Q2 2024 Earnings Call Transcript


Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript

May 2, 2024, 8:04 PM EDT - 1 year ago

Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript